Pulmonary Rehabilitation Frequency in COPD Patients
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorHospital Universitario Fundación Alcorcón
About this trial
Chronic obstructive pulmonary disease (COPD) is a common condition that can cause breathlessness and reduced physical capacity. Pulmonary rehabilitation (PR) is an effective treatment, but traditional programs often require patients to attend sessions several times per week, which may limit participation.
This study aims to compare the effectiveness of two supervised pulmonary rehabilitation programs: one performed 3 days per week and another performed 1 day per week, both over an 8-week period and including additional home-based exercises.
The main objective is to determine whether the lower-frequency program is not inferior to the higher-frequency program in improving functional capacity, measured by the six-minute walk test. Secondary outcomes include dyspnea, quality of life, muscle strength, physical activity, adherence, exacerbations, and safety.
The results of this study may help optimize pulmonary rehabilitation programs and improve accessibility for patients with COPD.
Eligibility criteria
Qualifiers
Modified Medical Research Council (mMRC) dyspnoea scale ≥2
Ability to actively participate and perform physical exercise
Signed informed consent
Disqualifiers
Unstable cardiac or musculoskeletal comorbidity contraindicating or limiting exercise
Moderate to severe cognitive impairment or inability to understand instructions
Recent participation (<6 months) in a complete pulmonary rehabilitation programme
Inability to attend the centre 1-3 days/week according to group allocation
Trial design
Treatments tested in this trial
- Pulmonary Rehabilitation
Treatment groups
158 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov